Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of PBK_L2201 in postmenopausal women with osteoporosis is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• PBK_L2201

Snippet

Sponsor: Pharmbio Korea Co., Ltd. | Conditions: Osteoporosis | Phase 3 | Status: UNKNOWN